AmyLi-HwaSunMDPhD
Hematology • Brooklyn, NYHematologic Oncology
Clinical Assistant Professor, NYU Langone
Dr. Sun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5718 Second Avenue
Brooklyn, NY 11220- Is this information wrong?
Summary
- Amy Sun, MD, is an Oncologist currently practicing in Brooklyn, NY. She completed her medical degree and PhD at the New York University School of Medicine (2017) and continued her training with a residency in Internal Medicine at NYU Grossman School of Medicine (2017-2020). Dr. Sun has numerous publications in recognized journals such as Nature and The Journal of Experimental Medicine. Her work focuses on a range of topics, including synthetic IL-9 receptors, MDR1 transporter function in cytotoxic T lymphocytes, and SATB1 expression in Sézary Syndrome. Dr. Sun's published research has been widely recognized and cited in other professional publications.
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 2017 - 2020- New York University School of MedicineClass of 2017
Certifications & Licensure
NY State Medical License 2024 - 2026
CA State Medical License 2020 - 2024- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 75 citationsT Cell-Derived IL-17 Mediates Epithelial Changes in the Airway and Drives Pulmonary NeutrophiliaLaura K Fogli, Mark S. Sundrud, Swati Goel, Sofia Bajwa, Kari Jensen
Journal of Immunology. 2013-09-15 - 68 citationsRole of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell LymphomaMelania H Fanok, Amy Sun, Laura K Fogli, Vijay Narendran, Miriam Eckstein
The Journal of Investigative Dermatology. 2018-05-01 - 49 citationsPotentiating adoptive cell therapy using synthetic IL-9 receptors.Anusha Kalbasi, Mikko Siurala, Leon L Su, Mito Tariveranmoshabad, Lora K Picton
Nature. 2022-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
